Figure 6
From: Evaluation of drug-targetable genes by defining modes of abnormality in gene expression
Kaplan-Meier survival analysis for grouped datasets.
The Whole breast cancer dataset was divided into two groups according to the expression levels of drug target genes (PTPRF, PRKAR2B, MAP4K3 and RICTOR). Grouped datasets were subjected to Kaplan-Meier survival analysis to compare DMFS, RFS and OS. Significantly different survival curves according to log-rank test are shown (for (A,B,C), P < 0.0001, P = 0.0096 and P = 0.023, respectively).
